U.S. FDA advisers vote in favor of Pfizer/BioNTech COVID-19 vaccine in young kids
Tweet
Share
E-mail
FILE PHOTO: A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic
(Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration on Tuesday voted to recommend the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages five to 11 years.
(Reporting by Manas Mishra in Bengaluru; Editing by Bill Berkrot)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Niagen Bioscience: Study links CD38 enzyme to NAD+ decline in aging placental tissue
- FDA grants priority review to Insmed's Arikayce for MAC lung disease
- Japan approves Merck's subcutaneous pembrolizumab for all Keytruda uses
Create E-mail Alert Related Categories
FDA, Hot FDA News, ReutersRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
